Normal view MARC view ISBD view

Neuromodulatory control of localized dendritic spiking in critical period cortex. [electronic resource]

By:

Yaeger, Courtney E

Contributor(s):

Producer: 20190805Description: 100-104 p. digitalISSN:

1476-4687

Subject(s): Online resources:

Available from publisher's website

In: Nature vol. 567

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, N.I.H., Extramural

There are no comments on this title.

to post a comment.

Back to results

501 Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
by Towbin, J A
502 Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.
by Rojek, Jillian M
503 A novel homozygous ISPD gene mutation causing phenotype variability in a consanguineous family.
by Baranello, Giovanni
504 Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification.
by Ervasti, J M
505 Several dystrophin-glycoprotein complex members are present in crude surface membranes but they are sodium dodecyl sulphate invisible in KCl-washed microsomes from mdx mouse muscle.
by Daval, Stéphanie
506 Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I.
by Darin, N
507 Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
by Godfrey, Caroline
508 Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.
by Chicoine, Louis G
509 Clinical features of the myasthenic syndrome arising from mutations in GMPPB.
by Rodríguez Cruz, Pedro M
510 Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG.
by van Tol, Walinka
511 Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
by Wakefield, P M
512 Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
by Voglmeir, Josef
513 A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features.
by Di Rosa, Gabriella
514 Ixodes scapularis dystroglycan-like protein promotes Borrelia burgdorferi migration from the gut.
by Coumou, Jeroen
515 Laminin β2 Chain Regulates Retinal Progenitor Cell Mitotic Spindle Orientation via Dystroglycan.
by Serjanov, Dmitri
516 Dystroglycan is a scaffold for extracellular axon guidance decisions.
by Lindenmaier, L Bailey
517 Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy.
by Matsumura, K
518 Clinical heterogeneity of adhalin deficiency.
by Morandi, L
519 Dystroglycan binds nerve and muscle agrin.
by Sugiyama, J
520 Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration.
by Masaki, T